載入...
Dose-Dense Nonpegylated Liposomal Doxorubicin and Docetaxel Combination in Breast Cancer: Dose-Finding Study
BACKGROUND. Anthracyclines and taxanes are effective drugs in breast cancer (BC), but their toxicity profiles limit their use in combination. A dose-finding study was performed to determine maximum tolerated doses (MTDs) of nonpegylated liposomal doxorubicin (TLC-D99) and docetaxel (DTX) as a dose-d...
Na minha lista:
發表在: | Oncologist |
---|---|
Main Authors: | , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
AlphaMed Press
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4319623/ https://ncbi.nlm.nih.gov/pubmed/25601964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0129 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|